Radiopharmaceuticals Market Size (USD 13515.27 M) by 2032 By Types (Diagnostic Radioisotopes, Therapeutic Radioisotopes) , Applications (Oncology, Cardiology, Other) and Regional Forecast to 2032

Detailed TOC of Global Radiopharmaceuticals Market Research Report 2024(Status and Outlook)

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Radiopharmaceuticals Segment by Type
1.2.2 Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Radiopharmaceuticals Market Overview
2.1 Global Market Overview
2.1.1 Global Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Radiopharmaceuticals Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Radiopharmaceuticals Market Competitive Landscape
3.1 Global Radiopharmaceuticals Sales by Manufacturers (2019-2024)
3.2 Global Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
3.3 Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Radiopharmaceuticals Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Radiopharmaceuticals Sales Sites, Area Served, Product Type
3.6 Radiopharmaceuticals Market Competitive Situation and Trends
3.6.1 Radiopharmaceuticals Market Concentration Rate
3.6.2 Global 5 and 10 Largest Radiopharmaceuticals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Radiopharmaceuticals Industry Chain Analysis
4.1 Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Radiopharmaceuticals Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Radiopharmaceuticals Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceuticals Sales Market Share by Type (2019-2024)
6.3 Global Radiopharmaceuticals Market Size Market Share by Type (2019-2024)
6.4 Global Radiopharmaceuticals Price by Type (2019-2024)
7 Radiopharmaceuticals Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceuticals Market Sales by Application (2019-2024)
7.3 Global Radiopharmaceuticals Market Size (M USD) by Application (2019-2024)
7.4 Global Radiopharmaceuticals Sales Growth Rate by Application (2019-2024)
8 Radiopharmaceuticals Market Segmentation by Region
8.1 Global Radiopharmaceuticals Sales by Region
8.1.1 Global Radiopharmaceuticals Sales by Region
8.1.2 Global Radiopharmaceuticals Sales Market Share by Region
8.2 North America
8.2.1 North America Radiopharmaceuticals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Radiopharmaceuticals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Radiopharmaceuticals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Radiopharmaceuticals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Radiopharmaceuticals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bracco Imaging
9.1.1 Bracco Imaging Radiopharmaceuticals Basic Information
9.1.2 Bracco Imaging Radiopharmaceuticals Product Overview
9.1.3 Bracco Imaging Radiopharmaceuticals Product Market Performance
9.1.4 Bracco Imaging Business Overview
9.1.5 Bracco Imaging Radiopharmaceuticals SWOT Analysis
9.1.6 Bracco Imaging Recent Developments
9.2 Bayer
9.2.1 Bayer Radiopharmaceuticals Basic Information
9.2.2 Bayer Radiopharmaceuticals Product Overview
9.2.3 Bayer Radiopharmaceuticals Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Radiopharmaceuticals SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 Mallinckrodt
9.3.1 Mallinckrodt Radiopharmaceuticals Basic Information
9.3.2 Mallinckrodt Radiopharmaceuticals Product Overview
9.3.3 Mallinckrodt Radiopharmaceuticals Product Market Performance
9.3.4 Mallinckrodt Radiopharmaceuticals SWOT Analysis
9.3.5 Mallinckrodt Business Overview
9.3.6 Mallinckrodt Recent Developments
9.4 Nordion
9.4.1 Nordion Radiopharmaceuticals Basic Information
9.4.2 Nordion Radiopharmaceuticals Product Overview
9.4.3 Nordion Radiopharmaceuticals Product Market Performance
9.4.4 Nordion Business Overview
9.4.5 Nordion Recent Developments
9.5 Triad Isotopes
9.5.1 Triad Isotopes Radiopharmaceuticals Basic Information
9.5.2 Triad Isotopes Radiopharmaceuticals Product Overview
9.5.3 Triad Isotopes Radiopharmaceuticals Product Market Performance
9.5.4 Triad Isotopes Business Overview
9.5.5 Triad Isotopes Recent Developments
9.6 Lantheus
9.6.1 Lantheus Radiopharmaceuticals Basic Information
9.6.2 Lantheus Radiopharmaceuticals Product Overview
9.6.3 Lantheus Radiopharmaceuticals Product Market Performance
9.6.4 Lantheus Business Overview
9.6.5 Lantheus Recent Developments
9.7 IBA Group
9.7.1 IBA Group Radiopharmaceuticals Basic Information
9.7.2 IBA Group Radiopharmaceuticals Product Overview
9.7.3 IBA Group Radiopharmaceuticals Product Market Performance
9.7.4 IBA Group Business Overview
9.7.5 IBA Group Recent Developments
9.8 GE Healthcare
9.8.1 GE Healthcare Radiopharmaceuticals Basic Information
9.8.2 GE Healthcare Radiopharmaceuticals Product Overview
9.8.3 GE Healthcare Radiopharmaceuticals Product Market Performance
9.8.4 GE Healthcare Business Overview
9.8.5 GE Healthcare Recent Developments
9.9 China Isotope and Radiation
9.9.1 China Isotope and Radiation Radiopharmaceuticals Basic Information
9.9.2 China Isotope and Radiation Radiopharmaceuticals Product Overview
9.9.3 China Isotope and Radiation Radiopharmaceuticals Product Market Performance
9.9.4 China Isotope and Radiation Business Overview
9.9.5 China Isotope and Radiation Recent Developments
9.10 Jubilant Pharma
9.10.1 Jubilant Pharma Radiopharmaceuticals Basic Information
9.10.2 Jubilant Pharma Radiopharmaceuticals Product Overview
9.10.3 Jubilant Pharma Radiopharmaceuticals Product Market Performance
9.10.4 Jubilant Pharma Business Overview
9.10.5 Jubilant Pharma Recent Developments
9.11 Eli Lilly
9.11.1 Eli Lilly Radiopharmaceuticals Basic Information
9.11.2 Eli Lilly Radiopharmaceuticals Product Overview
9.11.3 Eli Lilly Radiopharmaceuticals Product Market Performance
9.11.4 Eli Lilly Business Overview
9.11.5 Eli Lilly Recent Developments
9.12 Advanced Accelerator Applications
9.12.1 Advanced Accelerator Applications Radiopharmaceuticals Basic Information
9.12.2 Advanced Accelerator Applications Radiopharmaceuticals Product Overview
9.12.3 Advanced Accelerator Applications Radiopharmaceuticals Product Market Performance
9.12.4 Advanced Accelerator Applications Business Overview
9.12.5 Advanced Accelerator Applications Recent Developments
9.13 SIEMENS
9.13.1 SIEMENS Radiopharmaceuticals Basic Information
9.13.2 SIEMENS Radiopharmaceuticals Product Overview
9.13.3 SIEMENS Radiopharmaceuticals Product Market Performance
9.13.4 SIEMENS Business Overview
9.13.5 SIEMENS Recent Developments
9.14 Dongcheng
9.14.1 Dongcheng Radiopharmaceuticals Basic Information
9.14.2 Dongcheng Radiopharmaceuticals Product Overview
9.14.3 Dongcheng Radiopharmaceuticals Product Market Performance
9.14.4 Dongcheng Business Overview
9.14.5 Dongcheng Recent Developments
9.15 Navidea
9.15.1 Navidea Radiopharmaceuticals Basic Information
9.15.2 Navidea Radiopharmaceuticals Product Overview
9.15.3 Navidea Radiopharmaceuticals Product Market Performance
9.15.4 Navidea Business Overview
9.15.5 Navidea Recent Developments
10 Radiopharmaceuticals Market Forecast by Region
10.1 Global Radiopharmaceuticals Market Size Forecast
10.2 Global Radiopharmaceuticals Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Radiopharmaceuticals Market Size Forecast by Country
10.2.3 Asia Pacific Radiopharmaceuticals Market Size Forecast by Region
10.2.4 South America Radiopharmaceuticals Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Radiopharmaceuticals by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Radiopharmaceuticals Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Radiopharmaceuticals by Type (2025-2030)
11.1.2 Global Radiopharmaceuticals Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Radiopharmaceuticals by Type (2025-2030)
11.2 Global Radiopharmaceuticals Market Forecast by Application (2025-2030)
11.2.1 Global Radiopharmaceuticals Sales (Kilotons) Forecast by Application
11.2.2 Global Radiopharmaceuticals Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings